Yvonne Yeung

Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study

Rebecca Tay, Yvonne Yeung, Fiona Chionh et al. · British Journal of Cancer · 2018 · 43 citations · Full text

Radichol Study, Gastrointestinal Oncology, Medicine +9

K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines

Yvonne Yeung, Fiona Chionh, Hoanh Tran et al. · Molecular Oncology · 2017 · 20 citations · Full text

Amplification Status, Pathology, Cancer Biology +18

Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets

Dmitri Mouradov, Wiphawan Wasenang, Ian Y. Luk et al. · iScience · 2019 · 20 citations · Full text

Phase II study of everolimus monotherapy as first-line treatment in advanced biliary tract cancer: RADichol.

Yvonne Yeung, Fiona Chionh, Timothy Price et al. · Journal of Clinical Oncology · 2014 · 16 citations

Surgical Oncology, Chemoprevention Strategy, Pathology +19